Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells

Abstract

loading...

About

This paper, published in 1950, received 372 indexed citations. Written by Pablo Baquero, Alison M. Michie, Karen Dunn, Saverio Tardito, Tessa L. Holyoake, G. Vignir Helgason and Eyal Gottlieb covering the research area of Rheumatology and Hematology. It is primarily cited by scholars working on Molecular Biology (278 citations), Cancer Research (147 citations) and Hematology (126 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm.4399 →

Countries where authors are citing Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells

Since Specialization
Citations

This map shows the geographic impact of Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells more than expected).

Fields of papers citing Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm.4399.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026